These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 2258302)

  • 21. Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome.
    Bulpitt KJ; Verity MA; Clements PJ; Paulus HE
    Arthritis Rheum; 1990 Jul; 33(7):918-29. PubMed ID: 2369428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Eosinophilia-myalgia syndrome].
    Reinauer S; Plewig G
    Hautarzt; 1991 Mar; 42(3):137-9. PubMed ID: 2055761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?
    Shulman LE
    J Rheumatol; 1984 Oct; 11(5):569-70. PubMed ID: 6542592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-tryptophan induced eosinophilia-myalgia syndrome.
    Chartash EK; Given WP; Vishnubhakat SM; Susin M; Coffey EL; Farmer PM; Albanese JM; Kaplan MH; Furie RA
    J Rheumatol; 1990 Nov; 17(11):1527-33. PubMed ID: 2273498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of L-tryptophan-induced eosinophilia-myalgia resulting in death.
    Marks DR
    Conn Med; 1990 Oct; 54(10):552-4. PubMed ID: 2265542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eosinophilia-myalgia syndrome].
    Sieb JP; Scholten T; Beyenburg S; Uerlich M; Hebborn G
    Nervenarzt; 1991 Jun; 62(6):369-73. PubMed ID: 1876221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic fasciitis associated with L-tryptophan ingestion.
    Hamilton ME
    Ann Rheum Dis; 1991 Jan; 50(1):55-6. PubMed ID: 1994870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease.
    Kaufman LD; Seidman RJ; Phillips ME; Gruber BL
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1063-9. PubMed ID: 2273104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.
    Varga J; Peltonen J; Uitto J; Jimenez S
    Ann Intern Med; 1990 Mar; 112(5):344-51. PubMed ID: 2306063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
    Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
    Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistochemical studies on pathogenetic features of diffuse fasciitis].
    Takano A; Honda H; Inukai A; Takamidoh H; Takahashi A
    Rinsho Shinkeigaku; 1995 May; 35(5):492-9. PubMed ID: 7664516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
    Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
    J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
    Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
    J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two cases of L-tryptophan ingestion induced eosinophilia-myalgia syndrome].
    Mizutani T; Mizutani H; Hashimoto K; Kishida M; Taniguchi H; Okada H; Murata M; Nakamura Y; Shimizu M
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):561-6. PubMed ID: 1890752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome.
    DeSchryver-Kecskemeti K; Gramlich TL; Crofford LJ; Rader JI; Page SW; Needham LL; Hill RH; Sternberg EM
    Mod Pathol; 1991 May; 4(3):354-7. PubMed ID: 2068062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic features of the L-tryptophan-related eosinophilia-myalgia (fasciitis) syndrome.
    Winkelmann RK; Connolly SM; Quimby SR; Griffing WL; Lie JT
    Mayo Clin Proc; 1991 May; 66(5):457-63. PubMed ID: 1709432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-tryptophan-related eosinophilia-myalgia syndrome: a case report.
    Wong CB; Love J; Pon E; Scottolini AG; Manoukian AA
    Hawaii Med J; 1990 Aug; 49(8):295-8, 303. PubMed ID: 2211094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.
    Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ
    Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.